Recently, a comprehensive study in non-small cell lung cancer demonstrated that reduction in STAT3 in the tumor microenvironment using an antisense oligonucleotide reversed immunotherapy resistance in preclinical STK11 knockout mouse models [49]. This evidence concerns the gene STK11 and non-small cell lung carcinoma.